Skip to main content
MLEC
NASDAQ Manufacturing

Moolec Science Reports Going Concern Doubt Amid Subsidiary Bankruptcies and Liquidity Challenges

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
9
Price
$9
Mkt Cap
$6.056M
52W Low
$3.077
52W High
$157.05
Market data snapshot near publication time

summarizeSummary

Moolec Science SA disclosed a going concern warning in its latest financial report, citing severe liquidity issues and the loss of major subsidiaries through bankruptcy and debt enforcement, despite a one-time accounting gain from deconsolidation.


check_boxKey Events

  • Going Concern Warning Issued

    The company disclosed a material uncertainty regarding its ability to continue as a going concern, citing a negative working capital position and insufficient financial resources.

  • Loss of Key Subsidiaries

    Moolec Science lost control over Bioceres S.A. and Bioceres LLC due to voluntary bankruptcy proceedings, and previously lost control over BIOX due to debt enforcement and litigation.

  • Severe Liquidity Issues

    As of December 31, 2025, the company reported a negative working capital position, indicating significant challenges in meeting short-term obligations.

  • One-Time Accounting Gain from Deconsolidation

    The loss of control over Bioceres S.A. and Bioceres LLC resulted in a non-operational gain of approximately $129.3 million, which significantly impacted reported profit for the period.


auto_awesomeAnalysis

Moolec Science SA's interim financial statements reveal a material uncertainty regarding its ability to continue as a going concern, driven by a negative working capital position and limited access to financing. The company experienced significant changes in its operational scope due to the loss of control over key subsidiaries, including Bioceres S.A., Bioceres LLC, and previously BIOX, primarily due to bankruptcy proceedings and debt enforcement. While the deconsolidation of these entities resulted in a one-time accounting gain of $129.3 million, this masks underlying operational losses and severe financial distress. A $6 million credit line from a major shareholder's subsidiary offers some short-term liquidity, but the company's long-term viability remains uncertain without further funding.

At the time of this filing, MLEC was trading at $9.00 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $6.1M. The 52-week trading range was $3.08 to $157.05. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed MLEC - Latest Insights

MLEC
May 13, 2026, 9:17 PM EDT
Filing Type: 6-K
Importance Score:
9
MLEC
May 13, 2026, 5:19 PM EDT
Filing Type: 6-K
Importance Score:
8
MLEC
Apr 29, 2026, 9:04 AM EDT
Source: Access Newswire
Importance Score:
8
MLEC
Apr 07, 2026, 8:07 AM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
MLEC
Apr 07, 2026, 8:00 AM EDT
Source: Access Newswire
Importance Score:
8
MLEC
Apr 02, 2026, 2:46 PM EDT
Filing Type: 6-K
Importance Score:
9
MLEC
Jan 30, 2026, 4:41 PM EST
Filing Type: 6-K
Importance Score:
9
MLEC
Jan 23, 2026, 6:30 PM EST
Filing Type: 6-K
Importance Score:
8
MLEC
Jan 22, 2026, 9:25 AM EST
Filing Type: 6-K
Importance Score:
9
MLEC
Jan 06, 2026, 6:03 AM EST
Filing Type: 6-K
Importance Score:
7